Related Experiment Video
Updated: Jun 25, 2026

Probing Myosin Ensemble Mechanics in Actin Filament Bundles Using Optical Tweezers
Published on: May 4, 2022
Dilated cardiomyopathy mutations in alpha-tropomyosin inhibit its movement during the ATPase cycle
Yurii S Borovikov1, Olga E Karpicheva, Galina A Chudakova
1Laboratory of Mechanisms of Cell Motility, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Avenue, 194064 St. Petersburg, Russia. boroviko@mail.cytspb.rssi.ru
Insights
Dilated cardiomyopathy (DCM) mutations in alpha-tropomyosin alter its position and actin affinity on muscle thin filaments. These structural changes explain reduced Ca2+-sensitivity and activation observed in DCM patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Dilated cardiomyopathy (DCM) is a severe heart condition.
- Mutations in alpha-tropomyosin, specifically Glu40Lys and Glu54Lys, are linked to DCM.
- These mutations impair cardiac muscle function by decreasing thin filament Ca2+-sensitivity.
Purpose of the Study:
- To elucidate the molecular mechanisms behind the functional deficits caused by Glu40Lys and Glu54Lys alpha-tropomyosin mutations.
- To correlate structural changes in tropomyosin with observed functional impairments in DCM.
Main Methods:
- Labeling wild-type and mutant (Glu40Lys, Glu54Lys) alpha-tropomyosin with a fluorescent probe at Cys190.
- Incorporating labeled tropomyosin into ghost muscle fibers.
- Utilizing polarized fluorimetry to measure tropomyosin position on the thin filament and its actin affinity throughout the ATPase cycle.
Main Results:
- Both DCM-associated mutations shifted tropomyosin towards the thin filament periphery.
- Mutations altered tropomyosin's affinity for actin.
- The amplitude of tropomyosin movement during the ATPase cycle was reduced, and in some stages, reversed.
Conclusions:
- Structural alterations in tropomyosin, including altered position and actin binding, underlie the reduced Ca2+-sensitivity and activation in DCM.
- These findings provide a molecular basis for understanding alpha-tropomyosin-linked dilated cardiomyopathy.
Abstract:
The Glu40Lys and Glu54Lys mutations in alpha-tropomyosin cause dilated cardiomyopathy (DCM). Functional analysis has demonstrated that both mutations decrease thin filament Ca2+-sensitivity and that Glu40Lys reduces maximum activation. To understand the molecular mechanism underlying these changes, we labeled wild type alpha-tropomyosin and both mutants at Cys190 with 5-iodoacetamide-fluorescein and incorporated the labeled proteins into ghost muscle fibers. Using the polarized fluorimetry, the position of the labeled tropomyosins on the thin filament and their affinity for actin were measured and the change in these parameters at different stages of the ATPase cycle determined. Both DCM mutations were found to shift tropomyosin towards the periphery of thin filament and to change the affinity of tropomyosin for actin; during the ATPase cycle the amplitude of tropomyosin movement was reduced and at some stages of the cycle even reversed. The correlation of these structural changes with the observed function effects is discussed.
Related Concept Videos
ATP Synthase: Mechanism
ATP Synthase: Structure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cross-bridge Cycle
Mechanical Protein Functions
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
